Literature DB >> 8930223

Antibiotic use during the first 200 days of life.

G R Bergus1, B T Levy, S M Levy, S L Slager, M C Kiritsy.   

Abstract

To examine the use of antibiotics by infants in eastern Iowa, longitudinal data were collected from a cohort recruited at birth from 8 hospitals. Parents of recruited children were mailed questionnaires 6 weeks, 3 months, and 6 months after birth. Cumulative rates of use were determined by means of life tables for any antibiotic as well as by type of antibiotic. Factors associated with antibiotic use and patterns of use were also determined. There were data for 789 children. Antibiotic use was common in our cohort and increased with age. At 50, 100, 150, and 200 days of life, 8.7%, 26.7%, 37.3%, and 70.5%, respectively, of the infants had used at least 1 antibiotic. Infants were most frequently treated with amoxicillin, followed by cephalosporins and sulfonamides. Otitis media was the illness that most commonly prompted the use of an antibiotic.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930223     DOI: 10.1001/archfami.5.9.523

Source DB:  PubMed          Journal:  Arch Fam Med        ISSN: 1063-3987


  4 in total

1.  Effect of single-dose amoxicillin on rat incisor odontogenesis: a morphological study.

Authors:  Kaido Kumazawa; Takashi Sawada; Takaaki Yanagisawa; Seikou Shintani
Journal:  Clin Oral Investig       Date:  2011-06-30       Impact factor: 3.573

Review 2.  Practical considerations when treating children with antimicrobials in the outpatient setting.

Authors:  L N Werk; H Bauchner
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

3.  Acute otitis media in children: a retrospective analysis of physician prescribing patterns.

Authors:  Caroline Quach; Jean-Paul Collet; Jacques LeLorier
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

4.  Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants.

Authors:  Katri Korpela; Anne Salonen; Outi Vepsäläinen; Marjo Suomalainen; Carolin Kolmeder; Markku Varjosalo; Sini Miettinen; Kaarina Kukkonen; Erkki Savilahti; Mikael Kuitunen; Willem M de Vos
Journal:  Microbiome       Date:  2018-10-16       Impact factor: 14.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.